197 related articles for article (PubMed ID: 11535996)
1. Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m(2)) cyclophosphamide.
Morandi P; Ruffini PA; Benvenuto GM; La Vecchia L; Mezzena G; Raimondi R
Bone Marrow Transplant; 2001 Aug; 28(3):277-82. PubMed ID: 11535996
[TBL] [Abstract][Full Text] [Related]
2. [Assessment of cardiotoxicity of high dose cyclophosphamide with electrocardiographic, echocardiographic, and troponin I monitoring in patients with breast tumors].
Benvenuto GM; La Vecchia L; Morandi P; Ruffini P; Mezzena G
Ital Heart J Suppl; 2000 Nov; 1(11):1457-63. PubMed ID: 11109196
[TBL] [Abstract][Full Text] [Related]
3. Cardiac conduction abnormalities in patients with breast cancer undergoing high-dose chemotherapy and stem cell transplantation.
Ando M; Yokozawa T; Sawada J; Takaue Y; Togitani K; Kawahigashi N; Narabayashi M; Takeyama K; Tanosaki R; Mineishi S; Kobayashi Y; Watanabe T; Adachi I; Tobinai K
Bone Marrow Transplant; 2000 Jan; 25(2):185-9. PubMed ID: 10673678
[TBL] [Abstract][Full Text] [Related]
4. Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors.
Brockstein BE; Smiley C; Al-Sadir J; Williams SF
Bone Marrow Transplant; 2000 Apr; 25(8):885-94. PubMed ID: 10808211
[TBL] [Abstract][Full Text] [Related]
5. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
[TBL] [Abstract][Full Text] [Related]
6. Myocardial injury in scorpion envenomed children: significance of assessment of serum troponin I and interleukin-8.
Meki AR; El-Deen ZM; El-Deen HM
Neuro Endocrinol Lett; 2002 Apr; 23(2):133-40. PubMed ID: 12011799
[TBL] [Abstract][Full Text] [Related]
7. Cardiac findings in asymptomatic chronic hemodialysis patients with persistently elevated cardiac troponin I levels.
Katerinis I; Nguyen QV; Magnin JL; Descombes E
Ren Fail; 2008; 30(4):357-62. PubMed ID: 18569907
[TBL] [Abstract][Full Text] [Related]
8. High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study.
Bengala C; Danesi R; Guarneri V; Pazzagli I; Donati S; Favre C; Fogli S; Biadi O; Innocenti F; Del Tacca M; Mariani M; Conte PF
Bone Marrow Transplant; 2003 Feb; 31(4):275-80. PubMed ID: 12621462
[TBL] [Abstract][Full Text] [Related]
9. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
Horácek JM; Pudil R; Tichý M; Jebavý L; Strasová A; Praus R; Zák P; Malý J
Neoplasma; 2005; 52(5):430-4. PubMed ID: 16151589
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial.
Zander AR; Kröger N; Schmoor C; Krüger W; Möbus V; Frickhofen N; Metzner B; Schultze W; Berdel WE; Koenigsmann M; Thiel E; Wandt H; Possinger K; Trümper L; Kreienberg R; Carstensen M; Schmidt EH; Jänicke F; Schumacher M; Jonat W
J Clin Oncol; 2004 Jun; 22(12):2273-83. PubMed ID: 15111618
[TBL] [Abstract][Full Text] [Related]
11. Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancer.
Tiersten A; Wo J; Jacobson C; Weitzman A; Horwich T; Hesdorffer C; Savage D; Troxel A
Breast; 2004 Aug; 13(4):341-6. PubMed ID: 15325671
[TBL] [Abstract][Full Text] [Related]
12. Cardiac troponin I: is it a marker to detect cardiotoxicity in children treated with doxorubicin?
Köseoğlu V; Berberoğlu S; Karademir S; Kismet E; Yurttutan N; Demirkaya E; Sungur M; Alehan D
Turk J Pediatr; 2005; 47(1):17-22. PubMed ID: 15884624
[TBL] [Abstract][Full Text] [Related]
13. Cardiac toxicity of high-dose chemotherapy.
Morandi P; Ruffini PA; Benvenuto GM; Raimondi R; Fosser V
Bone Marrow Transplant; 2005 Feb; 35(4):323-34. PubMed ID: 15543194
[TBL] [Abstract][Full Text] [Related]
14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
15. [Cardiovascular risk markers in hemodialysis].
Urso S; Milone F; Garozzo M; Cannavò ME; Biondi A; Battaglia G
G Ital Nefrol; 2004; 21 Suppl 30():S212-6. PubMed ID: 15750988
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.
Peivandi AA; Dahm M; Opfermann UT; Peetz D; Doerr F; Loos A; Oelert H
Herz; 2004 Nov; 29(7):658-64. PubMed ID: 15580320
[TBL] [Abstract][Full Text] [Related]
17. Acute and late toxicity following adjuvant high-dose chemotherapy for high-risk primary operable breast cancer--a quality assessment study.
Svane IM; Homburg KM; Kamby C; Nielsen DL; Roer O; Sliffsgaard D; Johnsen HE; Hansen SW
Acta Oncol; 2002; 41(7-8):675-83. PubMed ID: 14651213
[TBL] [Abstract][Full Text] [Related]
18. Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimens.
Genre D; Viens P; Bertucci F; Chabannon C; Gravis G; Braud AC; Camerlo J; Houvenaeghel G; Moutardier V; Goncalvez A; Protière C; Bardou VJ; Maraninchi D
Bone Marrow Transplant; 2002 Jun; 29(11):881-6. PubMed ID: 12080351
[TBL] [Abstract][Full Text] [Related]
19. The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy.
Cheng YC; Rondón G; Yang Y; Smith TL; Gajewski JL; Donato ML; Shpall EJ; Jones R; Hortobagyi GN; Champlin RE; Ueno NT
Biol Blood Marrow Transplant; 2004 Nov; 10(11):794-804. PubMed ID: 15505610
[TBL] [Abstract][Full Text] [Related]
20. Clinical and non-invasive assessment of anthracycline cardiotoxicity: perspectives on myocardial protection.
Mortensen SA; Aabo K; Jonsson T; Baandrup U
Int J Clin Pharmacol Res; 1986; 6(2):137-50. PubMed ID: 3459718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]